The Bundeswehr Institute of Microbiology (IMB) is a military research facility of the German Armed Forces for Medical Biological Defence. Our mission is to develop methods and measures to protect soldiers from diseases caused by biological warfare agents and other dangerous pathogens.
IMB is committed to teaching, not only at the Bundeswehr Medical Academy but also at cooperating universities.
The Bundeswehr Institute of Microbiology has been supporting the diagnosis of this new viral infection since the end of January 2020, when the Institute became the first laboratory in Germany to diagnose SARS-CoV-2 infections in patients from Munich.
The Institute carries out translational research with the aim to develop products, knowledge and capabilities that can be directly or indirectly used for biological hazard prevention.
Under the Biosecurity Programme of the Federal Foreign Office and the Enable & Enhance Initiative of the Federal Government, IMB carries out projects in Georgia, Kazakhstan, Ukraine, Tunisia and the G5 Sahel region.